Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy

​ Conditions: Ig-E Mediated Food Allergy

Interventions: Drug: RPT904; Drug: RPT904; Other: Placebo; Drug: RPT904; Drug: RPT904; Other: Placebo

Sponsors: RAPT Therapeutics, Inc.

Recruiting Conditions: Ig-E Mediated Food Allergy
Interventions: Drug: RPT904; Drug: RPT904; Other: Placebo; Drug: RPT904; Drug: RPT904; Other: Placebo
Sponsors: RAPT Therapeutics, Inc.
Recruiting